Advertisement
  • Taking Drug Dosing Off Autopilot

    Patient advocates with metastatic breast cancer argue that dosing of treatments for their disease should be more personalized and take into account quality of life.

    by Marcus A. Banks

  • From the Editor-in-Chief

    Cancer in Minority Populations

    Paying attention to the social determinants of health will promote greater equity in cancer outcomes for all.

    by William G. Nelson, MD, PhD

  • More Choices to Treat Lung Cancer

    Advances in precision medicine and immunotherapy have led to better treatments for many patients with advanced lung cancer. But having a wider selection of therapies to choose from can make treatments more complex.

    by Kendall K. Morgan

  • Forward Look

    Creating More Inclusive Clinical Trials

    The Clinical Treatment Act aims to include more Medicaid recipients.

    by Jen Tota McGivney

  • Healthy Habits

    Ripe for the Picking

    Awareness of the link between cancer risk and a diet lacking fruits and vegetables has been declining.

    by Carisa D. Brewster

  • Forward Look

    Cancer Screening for the LGBTQ Community

    Fear of discrimination may lead to lower screening rates.

    by Tara Santora

  • Forward Look

    What’s Next

    A therapeutic vaccine targeting advanced cervical cancer.

    by Anna Azvolinsky

  • Worth the Wait

    Neoadjuvant therapy—using treatments such as chemotherapy, hormone therapy or radiation to shrink a tumor or treat unseen metastases before surgery—can improve outcomes for some patients.

    by Sharon Tregaskis

  • Facts and Stats

    A Brief History of Checkpoint Inhibitors

    The advent of checkpoint inhibitors has broadened the range of cancer patients able to take advantage of immunotherapy.

    by Bradley Jones

  • Targeted Therapy for Early-Stage Lung Cancer?

    A trial of the targeted therapy Tagrisso (osimertinib) for early-stage lung cancer finds that patients who take it go longer without having a cancer recurrence. Whether that should change clinical practice is under discussion.

    by Ashley P. Taylor

Advertisement

From the AACR

  • Genetics of Prostate Cancer

    Although there are many factors that can increase the risk for prostate cancer, for a significant number of men it can be inherited.

  • Liver Cancer Prevention

    The leading cause of liver cancer is infection with the hepatitis B virus or the hepatitis C virus.

  • Immunotherapy Resistance

    The majority of patients’ cancers don't respond to immune checkpoint inhibition. The reasons for this resistance remain unclear.

Advertisement

Video

Handle With Care

Advertisement

social media

donate to the AACR